Glenmark Pharmaceuticals
GLENMARK
₹ 1,451.85
₹ 10.45
0.72%
Healthcare
₹ 0.00
(%)1D
Updated: 22 Nov 2024, 02:35:29 pm IST
Stock Score
Open Price
₹ 1,447.50
Prev. Close
₹ 1,441.40
₹ 1,426.68
Day Low
₹ 1,463.93
Day High
₹ 739.56
52 Week Low
₹ 1,812.22
52 Week High
Quick Bite
Price To Earnings Ratio -27.29 | Sector PE 65.45 |
PB Ratio 5.23 | Sector PB 8.93 |
EPS -53.21 | Dividend Yield 0.26 |
Today's Volume 391.931 K | 5 Day Avg. Volume 705.433 K |
PEG Ratio 0.05 | Market Cap. ₹ 43,280.00 Cr. |
Returns Comparison
| Time | GLENMARK | VS | Industry |
|---|---|---|---|
| 1 Day | 0.73% | 1.42% | |
| 1 Week | -4.52% | 1.36% | |
| 1 Month | -11.69% | -0.56% | |
| 6 Months | 33.13% | 14.7% | |
| 1 Year | 93.8% | 46.06% |
Technical Trend
Bearish
Bearish
Neutral
Bullish
Pivot Levels
R3 ₹ 1,505.55
R2 ₹ 1,484.74
R1 ₹ 1,468.30
RESISTANCE
₹ 1,447.49
SUPPORT
S1 ₹ 1,431.05
S2 ₹ 1,410.24
S3 ₹ 1,393.80
Moving Averages
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
5
Buy
1
| Period (Days) | SMA | Indication |
|---|---|---|
| 10 | 1526.31 | Bearish |
| 20 | 1600.59 | Bearish |
| 30 | 1640.23 | Bearish |
| 50 | 1651.53 | Bearish |
| 100 | 1609.53 | Bearish |
| 200 | 1345.59 | Bullish |
Shareholding Updates
46.65%
Promoters
Sep 2024
Promoters 46.65%
FII 23.05%
DII 13.25%
Public 17.06%
Others 0.01%
Cash Flow
| Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -265.44 | 625.39 | 1108.65 | 1131.21 | |||||
| Investing Activities | 4560.89 | -528.49 | -333.28 | -675.24 | |||||
| Financing Activities | -3906.13 | -77.46 | -520.49 | -441.78 | |||||
| Net Cash Flow | 389.32 | 19.45 | 254.88 | 14.20 |
All Figures in ₹ Cr., unless mentioned otherwise
Ratios
Return on Equity (%)
Income Statement
All Figures in ₹ Cr., unless mentioned otherwise
Balance Sheet
All Figures in ₹ Cr., unless mentioned otherwise
Peer Comparison
| Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
|---|---|---|---|---|---|
| Glenmark Pharmaceuticals | 0.73 | -4.52 | -11.69 | 33.13 | 93.8 |
| Aarti Drugs | -1.1 | -3.17 | -6.83 | -2.53 | 2.88 |
| Abbott India | 2.2 | 0.61 | -3.67 | 3.31 | 20.57 |
| Advanced Enzyme Tech | -1.69 | -2.78 | -16.05 | -7.08 | 13.34 |
| Ajanta Pharmaceuticals | 1.18 | 5.73 | 2.08 | 13.83 | 47.7 |
Returns as on 22 Nov, 2024
About Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Limited is an India-based research-led, global pharmaceutical company. The Company hosts a diverse portfolio spanning branded, generics, and over the counter (OTC) segments. The Company is focused on the therapy areas of Respiratory, Dermatology and Oncology. The Company also has a regional/country-specific presence in other therapeutic areas like diabetes, cardiovascular and oral contraceptives. The Company's offerings include complex injectables and biologics, oral solids, liquids, topical products, respiratory mdi1/dpi2/nasal sprays. The Company is focused on developing products for markets such as India, Russia & CIS, Brazil, Asia and Africa. Its brands include RYALTRIS and SALMEX / ASTHMEX. RYALTRIS, the Company's first global branded specialty drug for treating symptoms of seasonal allergic rhinitis. The Company's subsidiaries include Glenmark Pharmaceuticals Inc., Ichnos Sciences Inc., and Glenmark Holding SA.
Glenmark Pharmaceuticals Share Price
Glenmark Pharmaceuticals Ltd has a significant presence in the branded generics market in all emerging economies including India. The company entered the dermatology market with the launch of Candid cream. Glenmark's pioneering drug development focuses primarily on inflammation [asthma/COPD, rheumatoid arthritis, etc.], metabolic disorders [diabetes, obesity, etc.] and pain [neuropathic pain and inflammatory pain]. The company's formulation business focuses on therapeutic areas, e.g. dermatology, infectious medicine, respiratory, cardiac, diabetes, gynecology, central nervous system and oncology. India is the organization's largest market region by revenue.
Glenmark Pharmaceuticals FAQs
How to Buy Glenmark Pharmaceuticals Share?
To purchase Glenmark Pharmaceuticals shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Glenmark Pharmaceuticals (ticker symbol: GLENMARK) on the trading platform provided by your broker and purchase the shares.
What's Glenmark Pharmaceuticals share price today?
The stock price of Glenmark Pharmaceuticals as of 22 Nov 2024 is ₹1,451.85
What is the Market Cap of Glenmark Pharmaceuticals?
Market capitalisation represents the total market value of a company's outstanding shares. As of 22 Nov 2024, Glenmark Pharmaceuticals (ticker symbol: GLENMARK) has a market capitalisation of approximately ₹4,32,80,00,00,000.00
What is the PE and PB ratio of Glenmark Pharmaceuticals?
Glenmark Pharmaceuticals Ltd's price-to-book ratio as of 22 Nov 2024 is 5.23, reflecting the market's valuation compared to its asset value. As of 22 Nov 2024, the trailing twelve months P/E (price-to-earnings) ratio is -27.29, indicating the market values the company at around - ₹27.29 for every ₹1 of earnings
What is the 52 Week High and Low of Glenmark Pharmaceuticals Share?
Glenmark Pharmaceuticals Ltd (GLENMARK) hit its 52-week high at ₹1,812.22, and its 52-week low at ₹739.56.
Want to learn and earn in Stocks?